News
-
-
-
NMPA Has Accepted The NDA of HLX01 (Rituximab Injection) for the Treatment of Rheumatoid Arthritis
2020-12-17
-
-
-
-
Henlius Adalimumab Biosimilar 汉达远® Approved by NMPA
2020-12-10
-
-
-
-
Hauck & Aufhäuser takes first step towards digital assets
2020-10-09
-
-
-
-
Investigational New Drug Application of Henlius SARS-CoV-2 Neutralizing Antibody HLX70 Approved by US FDA
2020-10-05
-
-
-
-
Henlius Released Phase 3 Study Data of its Bevacizumab Biosimilar HLX04 at CSCO 2020
2020-09-22
-
-
-
-
Opening of Hauck Investment Management (Shanghai) Co.
2020-09-22
-
-
-
-
Facilitating an Organisational Upgrade and Capitalising on European Opportunities
2020-09-21
-
-
-
-
WHO Adds Fosun Pharma’s Covid-19 Test to Its Emergency Use List
2020-09-11
-
-
-
-
Fosun successfully held FC2M Conference to expedite further industry operations development
2020-09-09
-
